Einloggen

Thematische Bibliographien / Biotechnology / Zeitschriftenartikel

Zeitschriftenartikel zum Thema „Biotechnology“

Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: Biotechnology.

Autor: Grafiati

Veröffentlicht am 4. Juni 2021

Zuletzt aktualisiert am 28. September 2024

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Biotechnology" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

Yaseen, Arshed H., Halah M. H. Al-Hasani und Umer Abdullah Ahmed Alelyan. „Biotechnology for medical diagnosis“. Drug and Pharmaceutical Science Archives 02, Nr. 01 (2022): 01–05. http://dx.doi.org/10.47587/dpsa.2022.2101.

Der volle Inhalt der Quelle

Annotation:

Biotechnology is broadly defined as, “using organisms or their products for commercial purposes” encompasses a wide range. Since the beginning of time, people have used (traditional) biotechnology. Wheat, brew alcohol, and breed food crops and domestic animals have all been made using this grain. Molecular biology’s most recent breakthroughs, on the other hand, have given new life to biotechnology’s relevance and potential. Biotechnology has become a hot topic among the general public. There’s a good chance that modern biotechnology will have a big impact on the environment. Small-molecule (chemical) medications produced by well-known pharmaceutical companies have traditionally accounted for the vast majority of human illness treatments. The current article discussed.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Adeyinka, Olawale Samuel, Oghenerobor Benjamin Akpor und Abimbola Pius Okiki. „Untapped potentials of Agricultural Biotechnology in Nigeria“. Journal of Bioscience and Biotechnology Discovery 6, Nr. 4 (30.10.2021): 33–37. http://dx.doi.org/10.31248/jbbd2021.152.

Der volle Inhalt der Quelle

Annotation:

The field of biotechnology has witnessed a significant achievement over the past decades. Although biotechnology always sparked a great deal of ethical criticism, the advancement has continued to offer an opportunity to address several social and economic challenges. The potentials of biotechnology remain underexploited in several fields in Nigeria. This review highlighted some untapped biotechnologies that represent an ample scope of biotechnology application used for the genetic improvement of plant and animal populations, conservation of genetic resources, and diagnosis of plant and animal diseases. Factors such as insufficient of funds to procure facilities, inadequate power supply, lack of sufficient trained manpower, lack of political will to support biotechnology has been limiting biotechnology's potentials in Nigeria. Therefore, it was recommended that attention should be given to biotechnology research and development to complement existing expertise in the national biotechnology sector towards maximizing its potentials.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

Sahu, Jyoti. „Future aspects of biotechnology and biological science in India“. Journal of Medical Pharmaceutical and Allied Sciences 2, Nr. 1 (Februar 2013): 33–37. http://dx.doi.org/10.55522/jmpas.v2i1.0007.

Der volle Inhalt der Quelle

Annotation:

Everybody wants to enter a field which is hot one such field is biotechnolog, Biotechnology has prcious scope, Its new and booming field and most important there is less saturation. Biotechnology is the offshoot of science in which livings being are used for production. Students, who have keen interest in Biotechnology and want to make their bright future in this field, have a lot of career opportunities in this field. Scientists, Pharmacists, Biomedical engineer, Medical scientists, Lecturer, Patent agents, Patent lawyer etc. Biotechnology is an interdisciplinary Science; it is like a growing tree. About a dozen of specialization branches of science like Biochemistry, Molecular biology, Cell biology, Bioinformatics, Chemical engineering, Food science, material science and so an these are the root of biotechnologynological tree, and animal health, Vaccine, Crop yields, Environmental monitoring, pollution control, Therapeutics are the applications of this branch. The term biotechnology was introduced by Karl Ereky in 1917. He used the term for large scale culture of pigs by the use of sugar beets the source of food material.. As biotechnology is a subject with lot of promises, students are getting attracted to this stream of science and with India emerging as one of the biggest leader in biotechnology.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

4

Boulay, Jean-Louis, und Sylvie Miot. „Chemical biotechnology Pharmaceutical biotechnology“. Current Opinion in Biotechnology 11, Nr. 6 (Dezember 2000): 515. http://dx.doi.org/10.1016/s0958-1669(00)00138-5.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

5

Boulay, Jean-Louis. „Pharmaceutical biotechnology: Chemical biotechnology“. Current Opinion in Biotechnology 10, Nr. 6 (Dezember 1999): 523–24. http://dx.doi.org/10.1016/s0958-1669(99)00022-1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

6

Verjan García, Noel. „Biotechnology, powerful tools for research and development“. Orinoquia 13, Nr. 1 (01.01.2009): 2. http://dx.doi.org/10.22579/20112629.217.

Der volle Inhalt der Quelle

Annotation:

ABSTRACT: The concept of biotechnology has been in the human mind since very ancient times, when the first human beings discovered the production of wine by fermenting fruit juices, the brewing beer industry, and the conversion of milk into cheese or yogurt. However, as these basic processes have going through a wide range of developments to supply specific requirements, biotechnology has evolved and some of its most dramatic advances were observed during in the last 30-years. Modern biotechnology begins with the ability to transfer a specific gene from one organism to another by using a set of genetic engineering techniques, thus recombinant DNA technology sparked an era o biotech revolution. This major achievement, together with the maintenance and growth of genetically uniform plant-and animal cell cultures increased dramatically the spectrum of biotechnology’s applications in disease prevention, treatment and quality of life.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

7

Zamora-González, Edgar Oswaldo, Angel Herráez, Paula Daniela Gutiérrez-Muñoz, Olivia Torres-Bugarín, María Valentina Toral-Murillo, Benjamín Gómez-Díaz, Cecilia Adriana Calderón-Reyes et al. „Implementation of Biotechnology Applied to Medicine Course Using Virtual Laboratories: Perceptions and Attitudes of Students“. Education Sciences 14, Nr. 2 (02.02.2024): 157. http://dx.doi.org/10.3390/educsci14020157.

Der volle Inhalt der Quelle

Annotation:

The rapid evolution of biotechnology across various sectors, including agriculture, industry, and medicine, has profoundly transformed our comprehension of the world. Virtual laboratories (VLs) provide an immersive learning experience that can enhance future generations’ understanding of biotechnology’s medical applications. This study investigated the impact of incorporating VLs into a short course on biotechnology applied to medicine on the attitudes and perceptions of third-year medical students (n = 210). A validated questionnaire was employed to assess their perspectives, attitudes, and experience with virtual laboratory platforms before and after the course. The findings revealed a significant positive change in 7/38 questionnaire items (p < 0.05), indicating that the VL experience modified perceptions about biotechnology. This study emphasizes the importance of exploring innovative teaching methods for biotechnology and highlights the advantages of VL in educating future physicians. The primary concerns of the students were the misuse of personal genetic information and biotechnological applications involving animal modification. Overall, the students had a favorable experience using the virtual laboratory platforms. These findings collectively suggest that VL can positively influence perceptions and attitudes toward biotechnology among healthcare professionals.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

8

Gábor, Miklós Gábor, und Ubul Pál Kralovánszky. „The father of the term ‘biotechnology’ was Hungarian: The forgotten works of Károly Ereky“. Acta Agraria Debreceniensis, Nr. 17 (14.09.2005): 107–10. http://dx.doi.org/10.34101/actaagrar/17/3279.

Der volle Inhalt der Quelle

Annotation:

In the Nature, Robert Bud gave an account of the fact that the generator of the concept "biotechnology" was the Hungarian Karl Ereky who, in his book published in Berlin in 1919 entitled "Biotechnologie der Fleisch-, Fett- und Milcherzeugung im landwirtschaftlichen Grossbetriebe" ("Biotechnology of Meat, Fat and Milk Production in a Large-Scale Agricultural Farm"), disclosed his observations and new views in that regard. Later on, Ereky's two essays, published in German language again, and other contemporary German sources have been processed which have confirmed the assumption whereas – in scientific terms – the further first applications of the expression "biotechnology" can be attributed to Ereky's works. Recently, we have explored and found biographical sources and documents which had been published by Ereky, which, however, have already been forgotten, by dint of which the story of origin of the first concept "biotechnology" can as well be clarified in a factual manner.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

9

Birkinshaw, Julian, Ivanka Visnjic und Simon Best. „Responding to a Potentially Disruptive Technology: How Big Pharma Embraced Biotechnology“. California Management Review 60, Nr. 4 (05.06.2018): 74–100. http://dx.doi.org/10.1177/0008125618778852.

Der volle Inhalt der Quelle

Annotation:

How do incumbent firms respond over time to a potentially disruptive technology? This article documents the strategies of 12 large pharmaceutical firms over 25 years as they addressed the opportunity/threat of biotechnology. All showed awareness of biotechnology’s potential, but their response profiles varied dramatically in terms of timing (early/late) and focus (external/internal). Late movers mostly made large acquisitions to “catch up,” but early movers maintained their lead in terms of biotechnology-based drug sales and profitability, and those with a more “open” response profile performed better. This response involves a three-step process: building awareness (sensing), building capability (responding), and building commitment (scaling).

APA, Harvard, Vancouver, ISO und andere Zitierweisen

10

Sapozhnikova, Alla Sapozhnikova, und Elena Pekhtasheva. „Collagen Applications in Biotechnology“. Indian Journal of Applied Research 4, Nr. 5 (01.10.2011): 625–27. http://dx.doi.org/10.15373/2249555x/may2014/197.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

11

Silpa, S. „Nanotechnology-Present Revolutionary Biotechnology“. International Journal of Pharma Research and Health Sciences 4, Nr. 4 (2016): 1261–67. http://dx.doi.org/10.21276/ijprhs.2016.04.03.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

12

Klyuchko, O. M. „CLUSTER ANALYSIS IN BIOTECHNOLOGY“. Biotechnologia Acta 10, Nr. 5 (Oktober 2017): 5–18. http://dx.doi.org/10.15407/biotech10.05.005.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

13

TAKATSUJI, Masamoto. „Biotechnology.“ Journal of the Japan Society for Precision Engineering 54, Nr. 1 (1988): 51–52. http://dx.doi.org/10.2493/jjspe.54.51.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

14

Santiago Vispo, Nelson. „Biotechnology“. Bionatura 1, Nr. 1 (15.01.2016): 3. http://dx.doi.org/10.21931/rb/2016.01.01.1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

15

Wickelgren, Ingrid. „Biotechnology“. Science News 135, Nr. 19 (13.05.1989): 300. http://dx.doi.org/10.2307/3973298.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

16

Sun, Marjorie. „Biotechnology“. Science 228, Nr. 4705 (14.06.1985): 1294–95. http://dx.doi.org/10.1126/science.228.4705.1294.b.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

17

Sun, Marjorie. „Biotechnology“. Science 228, Nr. 4705 (14.06.1985): 1294–95. http://dx.doi.org/10.1126/science.228.4705.1294-b.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

18

Mote, Patricia. „Biotechnology“. American Biology Teacher 70, Nr. 3 (01.03.2008): 173–74. http://dx.doi.org/10.2307/30163233.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

19

KAMAKURA, Takashi, Toshihiro NAGAMINE und Hideo OHKAWA. „BIOTECHNOLOGY“. Journal of Pesticide Science 19, Special (1994): S309—S313. http://dx.doi.org/10.1584/jpestics.19.special_s309.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

20

Bennett, Dawn D., und Julie Ann Miller. „Biotechnology“. Science News 127, Nr. 21 (25.05.1985): 329. http://dx.doi.org/10.2307/3969682.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

21

Morohoshi, Noriyuki. „Biotechnology.“ JAPAN TAPPI JOURNAL 41, Nr. 10 (1987): 983–91. http://dx.doi.org/10.2524/jtappij.41.983.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

22

Evens, Ronald P., und Mark Witcher. „Biotechnology“. Therapeutic Drug Monitoring 15, Nr. 6 (Dezember 1993): 514–20. http://dx.doi.org/10.1097/00007691-199312000-00011.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

23

HARLANDER, SUSAN K. „Biotechnology“. Nutrition Today 22, Nr. 4 (Juli 1987): 21–29. http://dx.doi.org/10.1097/00017285-198708000-00004.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

24

Cole-Turner, Ronald. „Biotechnology“. Theology Today 59, Nr. 1 (April 2002): 39–54. http://dx.doi.org/10.1177/004057360205900104.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

25

Cass, Tony, Jim Dunwell, Andrew J. Daugulis, Lawrence P. Wackett, Thomas A. Kost, Patrick Condreay, Jeroen Hugenholtz, Michiel Kleerebezem und Steve Projan. „Biotechnology“. Current Opinion in Biotechnology 11, Nr. 2 (April 2000): 109–14. http://dx.doi.org/10.1016/s0958-1669(00)00067-7.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

26

Cass, Tony, Jim Dunwell, Andrew J. Daugulis, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Jeroen Hugenholtz und Steve Projan. „Biotechnology“. Current Opinion in Biotechnology 11, Nr. 3 (Juni 2000): 219–25. http://dx.doi.org/10.1016/s0958-1669(00)00101-4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

27

Cass, Tony, Jim Dunwell, Andrew J. Dauglis, Thomas A. Kost, Patrick Condreay und Jeroen Hugenholtz. „Biotechnology“. Current Opinion in Biotechnology 11, Nr. 4 (August 2000): 309–13. http://dx.doi.org/10.1016/s0958-1669(00)00103-8.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

28

Cass, Tony, Jim Dunwell, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Steve Projan, Jeroen Hugenholtz und Michiel Kleerebezem. „Biotechnology“. Current Opinion in Biotechnology 12, Nr. 2 (April 2001): 113–19. http://dx.doi.org/10.1016/s0958-1669(00)00182-8.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

29

Dunwell, Jim, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Steve Projan, Jeroen Hugenholtz und Michiel Kleerebezem. „Biotechnology“. Current Opinion in Biotechnology 12, Nr. 3 (Juni 2001): 221–26. http://dx.doi.org/10.1016/s0958-1669(00)00203-2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

30

Cass, Tony, Jim Dunwell, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Steve Projan, Jeroen Hugenholtz, Nicholas J. Turner und Robert E. Speight. „Biotechnology“. Current Opinion in Biotechnology 12, Nr. 4 (August 2001): 321–28. http://dx.doi.org/10.1016/s0958-1669(00)00221-4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

31

Cass, Tony, Jim Dunwell, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Steven Projan et al. „Biotechnology“. Current Opinion in Biotechnology 13, Nr. 1 (Februar 2002): 1–8. http://dx.doi.org/10.1016/s0958-1669(02)00275-6.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

32

Dunwell, Jim, Lawrence P. Wackett, Thomas A. Kost, Patrick Condreay, Steven Projan, Jeroen Hugenholtz, Michiel Kleerebezem, Nicholas J. Turner und Robert E. Speight. „Biotechnology“. Current Opinion in Biotechnology 13, Nr. 2 (April 2002): 77–81. http://dx.doi.org/10.1016/s0958-1669(02)00289-6.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

33

Halliwell, Catherine, Tony Cass, Jim Dunwell, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay et al. „Biotechnology“. Current Opinion in Biotechnology 13, Nr. 4 (August 2002): 279–86. http://dx.doi.org/10.1016/s0958-1669(02)00342-7.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

34

Halliwell, Catherine, Tony Cass, Jim Dunwell, LawrenceP Wackett, Steven Projan, Jeroen Hugenholtz, Michiel Kleerebezem, NicholasJ Turner und RobertE Speight. „Biotechnology“. Current Opinion in Biotechnology 13, Nr. 5 (Oktober 2002): 407–11. http://dx.doi.org/10.1016/s0958-1669(02)00371-3.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

35

Cass, Tony, Jim Dunwell, Andrew J. Daugulis, Lawrence P. Wackett, Gianfranco Gilardi, Thomas A. Kost, Patrick Condreay, Jeroen Hugenholtz, Michiel Kleerebezem und Andrew J. Daugulis. „Biotechnology“. Current Opinion in Biotechnology 10, Nr. 6 (Dezember 1999): 517–22. http://dx.doi.org/10.1016/s0958-1669(99)00021-x.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

36

CASS, T., J. DUNWELL, L. WHACKETT, G. GILARDI, T. KOST, P. CONDREAY und D. POMPLIANO. „Biotechnology“. Current Opinion in Biotechnology 10, Nr. 2 (01.04.1999): 105–11. http://dx.doi.org/10.1016/s0958-1669(99)80018-4.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

37

Hecht, Hans-Jürgen, und Dieter Strack. „Biotechnology“. Phytochemistry 53, Nr. 5 (März 2000): 620. http://dx.doi.org/10.1016/s0031-9422(99)00588-9.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

38

Varela, Justo Corti. „Biotechnology“. European Journal of Risk Regulation 1, Nr. 1 (März 2010): 63–71. http://dx.doi.org/10.1017/s1867299x00000076.

Der volle Inhalt der Quelle

Annotation:

This section aims to update readers on decisions related to marketing products of modern biotechnology (e.g., GMOs, animal clones) at EU level and on national measures concerning their production. Special attention is devoted to problems of competence between Member States and the EU in regulating biotechnology issues; the institutional dynamics of decision making regarding products derived from modern biotechnology; the relationship between the EFSA and the EU institutions on green biotech-related issues; the evolution of EU regulatory framework and of national attitudes towards the risks and benefits of biotechnology derived products and their production. This section will also delve into the interaction between the EU legislation and WTO law regarding advances in the application of biotechnology within the agri-food value chain.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

39

Mereu, Claudio. „Biotechnology“. European Journal of Risk Regulation 2, Nr. 4 (Dezember 2011): 553–56. http://dx.doi.org/10.1017/s1867299x00001598.

Der volle Inhalt der Quelle

Annotation:

Regulation n. 1107/2009 of the European Parliament and Council of 21 October 2009 concerning the placing of plant protection products on the market entered into force on 14 December 2009 and applies as of 14 June 2011, subject to some transitional measures set out in Article 80. It shall replace gradually the current legislation on plant protection products which is laid down in Council Directive 91/414/EEC and related implementing Regulations.Broadly speaking, the harmonized authorization system for active substances used in plant protection products, as originally set out in Directive 91/414/ EEC, is maintained. Indeed, the placing on the market of plant protection products is still subject to a two-steps process whereby active substances are approved at the EU-level (with the inclusion into a “positive list” – Annex I to the new Regulation) while formulated products are authorised at the national level based on “Uniform Principles” laid down in a new implementing Regulation 546/2011. However, the criteria underlying each of these two steps have changed remarkably.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

40

GREGER, J. L. „Biotechnology“. Journal of the American Dietetic Association 100, Nr. 11 (November 2000): 1306–8. http://dx.doi.org/10.1016/s0002-8223(00)00370-9.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

41

Leigh, Ron. „Biotechnology“. Transactions of the Institute of Measurement and Control 19, Nr. 5 (Dezember 1997): 222. http://dx.doi.org/10.1177/014233129701900501.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

42

Bruhn, Christine M. „BIOTECHNOLOGY“. Nutrition Today 33, Nr. 1 (Januar 1998): 13–18. http://dx.doi.org/10.1097/00017285-199801000-00004.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

43

Lesch, William C., Cheryl J. Wachenheim und Bard S. Stillerad. „Biotechnology“. Health Marketing Quarterly 22, Nr. 3 (01.01.2005): 59–81. http://dx.doi.org/10.1300/j026v22n03_05.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

44

Byford, G. H. „Biotechnology“. Journal of Biomedical Engineering 10, Nr. 1 (Januar 1988): 3. http://dx.doi.org/10.1016/0141-5425(88)90019-2.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

45

Abrams, Fredrick R. „Biotechnology“. JAMA 289, Nr. 4 (22.01.2003): 488. http://dx.doi.org/10.1001/jama.289.4.488.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

46

White, William E. „Biotechnology“. Applied Biochemistry and Biotechnology 15, Nr. 1 (Juni 1987): 81–83. http://dx.doi.org/10.1007/bf02798507.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

47

Oniang'o, Ruth. „Biotechnology“. African Journal of Food, Agriculture, Nutrition and Development 9, Nr. 4 (25.06.2009): 1. http://dx.doi.org/10.18697/ajfand.25.ed018.

Der volle Inhalt der Quelle

Annotation:

The current issue of AJFAND covers a wide range of issues and also has a commentary on biotechnology by a world renown bio-philosopher, Prof Paul Thompson of the University of Toronto. Prof Thompson and I have known each other for close to a decade and have exchanged views on this issue to great length. Further, I have made arrangements for him to give lectures at the University of Nairobi and at Masinde Muliro University in Kenya.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

48

Oniang'o, Ruth. „Biotechnology“. African Journal of Food, Agriculture, Nutrition and Development 6, Nr. 1 (29.04.2006): 1. http://dx.doi.org/10.18697/ajfand.10.ed003.

Der volle Inhalt der Quelle

Annotation:

As we go to press, the World Trade Organization (WTO) has ruled in favor of a case that was pending before it against the EU for enforcing rules that were unfavorable to genetically modified foods or associated products from the United States of America .

APA, Harvard, Vancouver, ISO und andere Zitierweisen

49

Miot, Sylvie, und Jean-Louis Boulay. „Pharmaceutical biotechnology, Chemical biotechnology: Web alert“. Current Opinion in Biotechnology 13, Nr. 6 (Dezember 2002): 531–32. http://dx.doi.org/10.1016/s0958-1669(02)00383-x.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

50

Redaktion, TATuP. „Biotechnology ethics and public perceptions of biotechnology“. TATuP - Zeitschrift für Technikfolgenabschätzung in Theorie und Praxis 9, Nr. 4 (01.12.2000): 149. http://dx.doi.org/10.14512/tatup.9.4.149.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!